The forecast for leukemia mortality rates among men in Canada demonstrates a decreasing trend from 2024 to 2028, starting at 8.7 per 100,000 men and diminishing to 8.2 by 2028. The year-on-year reduction is subtle yet consistent, highlighting a steady decline of approximately 0.1 units or around 1-2% per annum. In 2023, the mortality rate was slightly higher, indicating an ongoing improvement in healthcare and treatment options over the forecast period. The five-year compound annual growth rate (CAGR) accentuates a similar downward trajectory.
Future trends to watch for include advancements in medical treatments, early diagnosis technologies, and public health initiatives that could further drive down leukemia mortality rates, alongside demographic changes and healthcare policy adjustments.
